UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction

Journal of cystic fibrosis, 2022-11, Vol.21 (6), p.922-936

2022

Volltextzugriff (PDF)

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals

Journal of cystic fibrosis, 2024-05, Vol.23 (3), p.388-397

2024

Volltextzugriff (PDF)

Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?

Clinical genetics, 2010-05, Vol.77 (5), p.464-473

2010

Volltextzugriff (PDF)

WS17.3 Platelet count enables early diagnosis of cystic fibrosis liver disease

Journal of cystic fibrosis, 2016-06, Vol.15, p.S28-S28

2016

Volltextzugriff (PDF)

144 Effect of treatment with ivacaftor on exhaled nitric oxide

Journal of cystic fibrosis, 2015-06, Vol.14, p.S95-S95

2015

Volltextzugriff (PDF)

Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis

Thorax, 2009-11, Vol.64 (11), p.932-938

2009

Volltextzugriff (PDF)

WS23.2 Characterization of the CFTR mutation c.3700A>G informs strategies for future medical intervention

Journal of cystic fibrosis, 2014-06, Vol.13, p.S43-S43

2014

Volltextzugriff (PDF)

Inhibition of Amiloride-Sensitive Epithelial Na+ Absorption by Extracellular Nucleotides in Human Normal and Cystic Fibrosis Airways

American journal of respiratory cell and molecular biology, 2000-12, Vol.23 (6), p.755-761

2000

Volltextzugriff (PDF)

WS1.2 Rate of decline in serum trypsinogen as a validation for the PIP score

Journal of cystic fibrosis, 2012-06, Vol.11, p.S1-S1

2012

Volltextzugriff (PDF)

A110 DGAT1 MUTATION OF LIPID TRAFFICKING ASSOCIATED WITH A RARE CASE OF CONGENITAL DIARRHEA

Journal of the Canadian Association of Gastroenterology, 2020-02, Vol.3 (Supplement_1), p.127-129

2020

Volltextzugriff (PDF)

122 Changes in lung clearance index in newborns who screened positive for cystic fibrosis with an inconclusive diagnosis

Journal of cystic fibrosis, 2022-10, Vol.21, p.S73-S73

2022

Volltextzugriff (PDF)

129 Tracking of lung function in children after clinical initiation of elexacaftor/tezacaftor/ivacaftor: a real-world setting

Journal of cystic fibrosis, 2024-09, Vol.23, p.S70-S70

2024

Volltextzugriff (PDF)

251 Using dashboard technology to visualize experimental cystic fibsosis data in real-time

Journal of cystic fibrosis, 2024-09, Vol.23, p.S133-S134

2024

Volltextzugriff (PDF)

WS14.6 Beta-adrenergic sweat secretion rate as accurate biomarker for CFTR function

Journal of cystic fibrosis, 2012-06, Vol.11, p.S32-S32

2012

Volltextzugriff (PDF)

Does the Macroduct ® collection system reliably define sweat chloride concentration in subjects with intermediate results?

Clinical biochemistry, 2009-08, Vol.42 (12), p.1260-1264

2009

Volltextzugriff (PDF)

712 Correlations between in-vitro and clinical drug response to CFTR modulators

Journal of cystic fibrosis, 2023-10, Vol.22, p.S393-S393

2023

Volltextzugriff (PDF)

Inconclusive diagnosis of cystic fibrosis after newborn screening

Pediatrics (Evanston), 2015-06, Vol.135 (6), p.e1377-e1385

2015

Volltextzugriff (PDF)

554 Mucosal inflammation of the colon and terminal ileum in peoplewith cystic fibrosis is mild and not associated with abdominal pain or presence of polyps

Journal of cystic fibrosis, 2023-10, Vol.22, p.S293-S293

2023

Volltextzugriff (PDF)

333 Assessing CFTR modulator response for an individual with H609R/ 2184insA using different in-vitro model systems

Journal of cystic fibrosis, 2023-10, Vol.22, p.S166-S166

2023

Volltextzugriff (PDF)

β-adrenergic stimulation alters sweat gland potential difference in cystic fibrosis (CF) patients but not healthy controls

Journal of cystic fibrosis, 2008-06, Vol.7, p.S24-S24

2008

Volltextzugriff (PDF)

Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers

Journal of medical genetics, 2003-07, Vol.40 (7), p.e88-88

2003

Volltextzugriff (PDF)

12 The relation between meconium ileus prevalence score and functional severity of CFTR mutations

Journal of cystic fibrosis, 2011, Vol.10, p.S3-S3

2011

Volltextzugriff (PDF)

284 P1013L is a class II mutation rescued by elexacaftor-tezacaftor-ivacaftor

Journal of cystic fibrosis, 2023-10, Vol.22, p.S143-S143

2023

Volltextzugriff (PDF)

CF diagnosis algorithms: challenging dogma

Journal of cystic fibrosis, 2010, Vol.9, p.S10-S10

2010

Volltextzugriff (PDF)

A novel paradigm for attributing the diagnosis of CF disease

Journal of cystic fibrosis, 2010, Vol.9, p.S10-S10

2010

Volltextzugriff (PDF)

1 – 25 von 629

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(551)
Mit Volltextzugriff
(531)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(320)
Life Sciences & Biomedicine
(240)
Humans
(228)
Male
(121)
Female
(114)
Cardiovascular System & Cardiology
(70)
Mathematics
(70)
Cardiac & Cardiovascular Systems
(69)
Physical Sciences
(68)
Aged
(67)
Middle Aged
(63)
Adult
(60)
Cystic Fibrosis
(47)
Cardiology
(45)
Pediatrics
(44)
Child
(41)
Gastroenterology & Hepatology
(38)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(36)
Adolescent
(34)
Mortality
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals

Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?

WS17.3 Platelet count enables early diagnosis of cystic fibrosis liver disease

144 Effect of treatment with ivacaftor on exhaled nitric oxide

Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis

WS23.2 Characterization of the CFTR mutation c.3700A>G informs strategies for future medical intervention

Inhibition of Amiloride-Sensitive Epithelial Na+ Absorption by Extracellular Nucleotides in Human Normal and Cystic Fibrosis Airways

WS1.2 Rate of decline in serum trypsinogen as a validation for the PIP score

A110 DGAT1 MUTATION OF LIPID TRAFFICKING ASSOCIATED WITH A RARE CASE OF CONGENITAL DIARRHEA

122 Changes in lung clearance index in newborns who screened positive for cystic fibrosis with an inconclusive diagnosis

129 Tracking of lung function in children after clinical initiation of elexacaftor/tezacaftor/ivacaftor: a real-world setting

251 Using dashboard technology to visualize experimental cystic fibsosis data in real-time

WS14.6 Beta-adrenergic sweat secretion rate as accurate biomarker for CFTR function

Does the Macroduct ® collection system reliably define sweat chloride concentration in subjects with intermediate results?

712 Correlations between in-vitro and clinical drug response to CFTR modulators

Inconclusive diagnosis of cystic fibrosis after newborn screening

554 Mucosal inflammation of the colon and terminal ileum in peoplewith cystic fibrosis is mild and not associated with abdominal pain or presence of polyps

333 Assessing CFTR modulator response for an individual with H609R/ 2184insA using different in-vitro model systems

β-adrenergic stimulation alters sweat gland potential difference in cystic fibrosis (CF) patients but not healthy controls

Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers

12 The relation between meconium ileus prevalence score and functional severity of CFTR mutations

284 P1013L is a class II mutation rescued by elexacaftor-tezacaftor-ivacaftor

CF diagnosis algorithms: challenging dogma

A novel paradigm for attributing the diagnosis of CF disease

Suchergebnisse filtern